Public and participant involvement as a pathway to inclusive dementia research
Sarah Walter(University of Southern California), Crystal M. Glover(Rush University Medical Center), Cynthia Sierra, Allison Gibson(Saint Louis University), Marlon M. P. Smeitink, Claire E. Sexton(Alzheimer's Association), Diana Karamacoska(Western Sydney University), Aida Suárez‐González(UK Dementia Research Institute), Sarah Gregory(University of Edinburgh), Doris P. Molina‐Henry(University of Southern California), Iracema Leroi(Trinity College Dublin), Ríona Mc Ardle(Newcastle University), Helen Bundy Medsger, Sandra Loyola Sandoval, Nancy Meserve, Emily A. Largent(University of Pennsylvania), Roland Samaroo, Rebecca M. Edelmayer(Alzheimer's Association)
Cited by 25
Related Papers
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
|Alzheimer s & Dementia|2022|589
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
|The Lancet Neurology|2009|460
Cognitive Impairment in Parkinson Disease
|Journal of Geriatric Psychiatry and Neurology|2012|380
Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease
|International Journal of Geriatric Psychiatry|2004|228
Neuropsychiatry of Huntington’s Disease and Other Basal Ganglia Disorders
|Psychosomatics|2000|223